Search

Stanley A Lorens

from Mount Pleasant, SC
Age ~88
Get Report
Also known as:
Stanely A Lorens, Stanley A Loren
Phone and address:
1906 Ventura Pl, Mount Pleasant, SC 29464
(843) 971-7155
Related to:
Katherine L Lorens, 39
Connected to:
Hadassah G Lorenscheit, 35Tracilla L Lorens, 74Jeanette E Lorensen, 60Paul H Lorensen, 74Aaron K Lorenson, 44Dennis D Lorenson, 47Jami J Lorenson, 48Jerry J Lorenson, 88Maggie LorentSophie D Lorent, 104

Stanley Lorens Phones & Addresses

  • 1906 Ventura Pl, Mt Pleasant, SC 29464 (843) 971-7155
  • Mount Pleasant, SC
  • 407 Park Ave, River Forest, IL 60305 (708) 488-9556
  • 1S111 Spring Rd, Oakbrook Terrace, IL 60181 (630) 617-5006
  • 20 Pine Ave, La Grange Park, IL 60526 (708) 482-7098 (708) 482-9161
  • La Grange Pk, IL
  • Forest Park, IL
  • Maywood, IL
  • Countryside, IL
  • Charleston, SC

Publications

Us Patents

Glycosaminoglycans Having An Average Molecular Weight Of 2400 D Suitable For The Treatment Of Senile Dementia

US Patent:
6979680, Dec 27, 2005
Filed:
May 12, 2000
Appl. No.:
10/048542
Inventors:
Umberto Cornelli - 20129 Milano, IT
Luigi De Ambrosi - Santhia', IT
Israel Hanin - Chicago IL, US
Jawed Fareed - Westchester IL, US
John Lee - Wilmette IL, US
Stanley Lorens - Forest Park IL, US
Ronald F. Mervis - Columbus OH, US
International Classification:
A01N043/04
US Classification:
514 56, 514 54
Abstract:
The present invention relates to the use of glycosaminoglycans having an average/molecular weight of 2,400 D for the preparation of pharmaceutical compositions suitable for the treatment of senile dementia, in particular for the treatment of Alzheimer's disease or SDAT (Senile Dementia Alzheimer's Type) and of the cerebral neurological lesions from ictus and from traumas.

Glycosaminoglycans For Treatment Of Emotional Dysfunctions

US Patent:
7812005, Oct 12, 2010
Filed:
May 19, 2004
Appl. No.:
10/557860
Inventors:
Umberto Cornelli - 20129 Milan, IT
Luigi De Ambrosi - Santhia′, IT
Stanley Lorens - Forest Park IL, US
Jawed Fareed - Westchester IL, US
John Lee - Wilmette IL, US
Israel Hanin - Chicago IL, US
Ronald Mervis - Columbus OH, US
International Classification:
A61K 31/726
A61K 31/715
A61K 31/727
A61K 31/737
US Classification:
514 54, 514 23, 514 56, 5361231
Abstract:
The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.

Method For The Enhancement Of Lymphocyte Activity Against Tumors

US Patent:
60544899, Apr 25, 2000
Filed:
Nov 17, 1997
Appl. No.:
8/971849
Inventors:
Stanley A. Lorens - Forest Park IL
Herbert L. Mathews - Elmhurst IL
John Clancy - Naperville IL
Joanna Goral - Woodridge IL
Brigitte Riveline - Paris, FR
Assignee:
Loyola University of Chicago - Maywood IL
International Classification:
A61K 31135
US Classification:
514654
Abstract:
The invention relates to the treatment of an immunocompromised human, e. g. , an AIDS or HIV positive patient, for the enhancement of lymphocyte activity against opportunistic microbial pathogens or the treatment of any human for the enhancement of lymphocyte activity against tumors using a lymphocyte-activity-enhancing amount of dextrofenfluramine or a pharmaceutically-acceptable acid addition salt thereof.

Method For The Enhancement Of Lymphocyte Activity Against Opportunistic Microbial Pathogens

US Patent:
59555084, Sep 21, 1999
Filed:
Oct 15, 1996
Appl. No.:
8/729868
Inventors:
Stanley A. Lorens - Forest Park IL
Herbert L. Mathews - Elmhurst IL
John Clancy - Naperville IL
Joanna Goral - Woodridge IL
Brigitte Riveline - Paris, FR
Assignee:
Loyola University of Chicago - Maywood IL
International Classification:
A61K 31135
US Classification:
514649
Abstract:
The invention relates to the treatment of an immunocompromised human, e. g. , an AIDS or HIV positive patient, for the enhancement of lymphocyte activity against opportunistic microbial pathogens or the treatment of any human for the enhancement of lymphocyte activity against tumors using a lymphocyte-activity-enhancing amount of dextrofenfluramine or a pharmaceutically-acceptable acid addition salt thereof.
Control profile
Stanley A Lorens from Mount Pleasant, SC, age ~88 Get Report